Warning letterFDA · Nov 14, 2022
Chambers' Apothecary MARCS-CMS 636306, November 14, 2022
Named company: Chambers' Apothecary
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Blood Pressure Support and CoEnzymeQ10 fail to…
